Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures.

The global Antiepileptic Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antiepileptic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antiepileptic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antiepileptic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antiepileptic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GlaxoSmithKline
Johnson & Johnson
Sanofi
Pfizer
Novartis
Abbott
Sunovion
Cephalon (Teva)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
First generation
Second generation

Segment by Application
Hosptial
Clinic
Research